EUVIMEDEUVIMED entdecken
Open Access

New‐Onset Atrial Fibrillation During ST‐Segment–Elevation Myocardial Infarction: Risk of Recurrence and Its Clinical Impact During 10 Years of Follow‐Up

Marina M Demidova iD, Maria A Baturova iD, David Erlinge iD, Pyotr G Platonov iD

Journal of the American Heart Association · 07.10.2025 · 14 (19)

DOI: 10.1161/jaha.124.040478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 07.10.2025. Verfasst von Marina M Demidova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Clinical Sciences Lund University Lund Sweden. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Atrial Fibrillation, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation (AF) often complicates ST‐segment–elevation myocardial infarction (STEMI), but data on AF recurrence after first‐ever AF during STEMI are scarce. We aimed at assessing the risk of AF recurrence after first‐ever transient AF during admission for STEMI.

Methods

We performed a single‐center, register‐based cohort study. Patients with STEMI discharged alive after primary percutaneous coronary intervention during 2007 to 2010 were followed until 2018. Clinical characteristics, date of AF diagnosis, and mortality status were retrieved from Swedish national registries. All ECGs recorded before, during, or after STEMI were reviewed. The primary end point was the first documented AF episode after discharge, and the secondary end point was mortality. The risk of AF during follow‐up was calculated using the Fine‐Gray subdistributional hazard model for AF and total mortality, regressed on prespecified clinical and demographic covariates. In patients with first‐ever transient AF during STEMI, we looked for the factors associated with AF recurrence.

Results

Of 2120 patients discharged alive, 127 (5.9%) had AF during admission for STEMI. Patients with AF during STEMI were more likely to develop AF during follow‐up (hazard ratio [HR], 4.82 [95% CI, 3.86–6.02]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ST Elevation Myocardial InfarctionAtrial FibrillationPercutaneous Coronary InterventionHumansFemaleMaleRecurrenceSwedenAgedFollow-Up StudiesMiddle AgedRisk FactorsElectrocardiographyRisk AssessmentRegistriesTime Factors

Stichwörter der Autor:innen

P waveSTEMIatrial fibrillation

Autor:innen und Institutionen

  • Department of Cardiology, Clinical Sciences Lund University Lund Sweden.
  • Department of Cardiac Physiology, Institute of Physiology Komi Science Center, Ural Branch, Russian Academy of Sciences Syktyvkar Russia.

ORCID-Profile: Marina M Demidova, Maria A Baturova, David Erlinge, Pyotr G Platonov

Zitieren

APA

Demidova, M. M., Baturova, M. A., Erlinge, D., & Platonov, P. G. (2025). New‐Onset Atrial Fibrillation During ST‐Segment–Elevation Myocardial Infarction: Risk of Recurrence and Its Clinical Impact During 10 Years of Follow‐Up. Journal of the American Heart Association, 14(19). https://doi.org/10.1161/jaha.124.040478

Vancouver

Demidova MM, Baturova MA, Erlinge D, Platonov PG. New‐Onset Atrial Fibrillation During ST‐Segment–Elevation Myocardial Infarction: Risk of Recurrence and Its Clinical Impact During 10 Years of Follow‐Up. Journal of the American Heart Association. 2025;14(19). doi:10.1161/jaha.124.040478

BibTeX
@article{Demidova2025,
  author = {Demidova, Marina M and Baturova, Maria A and Erlinge, David and Platonov, Pyotr G},
  title = {New‐Onset Atrial Fibrillation During ST‐Segment–Elevation Myocardial Infarction: Risk of Recurrence and Its Clinical Impact During 10 Years of Follow‐Up},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {19},
  doi = {10.1161/jaha.124.040478}
}
Kostenlos starten →